Protein Sciences will pitch Flublok to Connecticut home healthcare association; New biotech formed to develop cancer vaccines;

> Protein Sciences is partnering with the Connecticut Association for Healthcare at Home, which will enable it to sell its Flublok vaccine to member home-health and hospice agencies. News

> The Fight Against Cancer Innovation Trust and its partners formed Turnstone Biologics, a new biotech to develop cancer vaccines. Release

> A study published in Pediatrics showed that effectiveness of the Tdap vaccine for pertussis "decreases substantially" in adolescents after two to four years. News

> Gavi will continue to provide financial support for vaccinations and immunization programs in India, but only until 2020. Story

And Finally... The Chittoor District Medical and Health Department in India is scheduled to launch a pentavalent vaccine Thursday, but misspelled it as "pentaviolent" in a press release. An official went on to explain that the vaccine works "violently" against diseases. While a senior official later admitted the mistake, some continue to call it "violent." Story

Suggested Articles

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.

Shingrix sales in the second quarter plummeted by half from first-quarter levels, and recovery of vaccination rates remains slow amid the pandemic.